Effect of administration of intestinal anthelmintic drugs on haemoglobin: systematic review of randomised controlled trials
Effect of administration of intestinal anthelmintic drugs on haemoglobin: systematic review of randomised controlled trials
Objective: To evaluate the effect of routine administration of intestinal anthelmintic drugs on haemoglobin.
Design: Systematic review of randomised controlled trials.
Data sources: Electronic databases and hand search of reviews, bibliographies of books, and abstracts and proceedings of international conferences.
Study selection: Included studies were randomised or quasi-randomised controlled trials using an intestinal anthelmintic agent in the intervention group, in which haemoglobin was evaluated as an outcome measure. Trials in which treatment for schistosoma (praziquantel) was given exclusively to the intervention group were excluded.
Results: The search identified 14 eligible randomised controlled trials. Data were available for 7829 subjects, of whom 4107 received an anthelmintic drug and 3722 received placebo. The pooled weighted mean difference (random effect model) of the change in haemoglobin was 1.71 (95% confidence interval 0.70 to 2.73) g/l (P<0.001; test for heterogeneity: Cochran Q=51.17, P<0.001; I2=61% (37% to 76%)). With the World Health Organization's recommended haemoglobin cut-offs of 120 g/l in adults and 110 g/l in children, the average estimated reduction in prevalence of anaemia ranged from 1.1% to 12.4% in adults and from 4.4% to 21.0% in children. The estimated reductions in the prevalence of anaemia increased with lower haemoglobin cut-offs used to define anaemia.
Conclusions: Routine administration of intestinal anthelmintic agents results in a marginal increase in haemoglobin (1.71 g/l), which could translate on a public health scale into a small (5% to 10%) reduction in the prevalence of anaemia in populations with a relatively high prevalence of intestinal helminthiasis.
prevalence, parasitic, anthelmintics, drug effects, public health, randomized controlled trials, review, adult, drug therapy, research, epidemiology, abstract, humans, india, world health, administration & dosage, intestinal diseases, health, helminthiasis, hemoglobins
1-6
Gulani, Anjana
cb5b39a8-89f4-4d95-b961-c378b94f647d
Nagpal, Jitender
f2153711-6a3b-4865-b097-b1fff9354cf6
Osmond, Clive
2677bf85-494f-4a78-adf8-580e1b8acb81
Sachdev, H.P.S.
8667f0cc-a69a-4f5d-b140-14e06edd7894
26 May 2007
Gulani, Anjana
cb5b39a8-89f4-4d95-b961-c378b94f647d
Nagpal, Jitender
f2153711-6a3b-4865-b097-b1fff9354cf6
Osmond, Clive
2677bf85-494f-4a78-adf8-580e1b8acb81
Sachdev, H.P.S.
8667f0cc-a69a-4f5d-b140-14e06edd7894
Gulani, Anjana, Nagpal, Jitender, Osmond, Clive and Sachdev, H.P.S.
(2007)
Effect of administration of intestinal anthelmintic drugs on haemoglobin: systematic review of randomised controlled trials.
BMJ, 334 (7603), .
(doi:10.1136/bmj.39150.510475.AE).
Abstract
Objective: To evaluate the effect of routine administration of intestinal anthelmintic drugs on haemoglobin.
Design: Systematic review of randomised controlled trials.
Data sources: Electronic databases and hand search of reviews, bibliographies of books, and abstracts and proceedings of international conferences.
Study selection: Included studies were randomised or quasi-randomised controlled trials using an intestinal anthelmintic agent in the intervention group, in which haemoglobin was evaluated as an outcome measure. Trials in which treatment for schistosoma (praziquantel) was given exclusively to the intervention group were excluded.
Results: The search identified 14 eligible randomised controlled trials. Data were available for 7829 subjects, of whom 4107 received an anthelmintic drug and 3722 received placebo. The pooled weighted mean difference (random effect model) of the change in haemoglobin was 1.71 (95% confidence interval 0.70 to 2.73) g/l (P<0.001; test for heterogeneity: Cochran Q=51.17, P<0.001; I2=61% (37% to 76%)). With the World Health Organization's recommended haemoglobin cut-offs of 120 g/l in adults and 110 g/l in children, the average estimated reduction in prevalence of anaemia ranged from 1.1% to 12.4% in adults and from 4.4% to 21.0% in children. The estimated reductions in the prevalence of anaemia increased with lower haemoglobin cut-offs used to define anaemia.
Conclusions: Routine administration of intestinal anthelmintic agents results in a marginal increase in haemoglobin (1.71 g/l), which could translate on a public health scale into a small (5% to 10%) reduction in the prevalence of anaemia in populations with a relatively high prevalence of intestinal helminthiasis.
This record has no associated files available for download.
More information
Published date: 26 May 2007
Keywords:
prevalence, parasitic, anthelmintics, drug effects, public health, randomized controlled trials, review, adult, drug therapy, research, epidemiology, abstract, humans, india, world health, administration & dosage, intestinal diseases, health, helminthiasis, hemoglobins
Identifiers
Local EPrints ID: 61185
URI: http://eprints.soton.ac.uk/id/eprint/61185
ISSN: 0959-8138
PURE UUID: a338b1b1-c61c-41e4-b389-85e17cca4197
Catalogue record
Date deposited: 18 Nov 2008
Last modified: 16 Mar 2024 02:50
Export record
Altmetrics
Contributors
Author:
Anjana Gulani
Author:
Jitender Nagpal
Author:
H.P.S. Sachdev
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics